Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients
Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages p...
Gespeichert in:
| Veröffentlicht in: | Urologia internationalis 2015-01, Vol.94 (4), p.383-389 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 389 |
|---|---|
| container_issue | 4 |
| container_start_page | 383 |
| container_title | Urologia internationalis |
| container_volume | 94 |
| creator | Waldhoer, Thomas Berger, Ingrid Haidinger, Gerald Zielonke, Nadine Madersbacher, Stephan |
| description | Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (pT1 have a shorter cancer-specific and overall survival. |
| doi_str_mv | 10.1159/000368418 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_proquest_miscellaneous_1686414502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1686414502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-14f752ba39799bc30d41de61a78e53db7ba50bba78d73b207c2095328417259a3</originalsourceid><addsrcrecordid>eNpt0M9O20AQBvBV1aqk0AN3VI3US5Fi2D-219tbEiggRYBEUI_W2jtG2zq22bUjeAAOPAgvxpOwKGlOPY1G89M30kfIPqNHjCXqmFIq0ixm2QcyYjEXERVKfSQjSmMeMSayHfLF-z-UBqzkZ7LDk0yIOE1H5OkGH-DEVhU6bEr00Fbw-vzSLRhMa20MOpjpcHBwM7iVXekabAOTwffO6p8wgRP0pbNdb1c4hnnb3EULdMsxXOretk302xqESaPrR289TLVHA20DXI6lFHAdEDa93yOfKl17_LqZu-T21-lidh7Nr84uZpN5VIpU9RGLK5nwQgsllSpKQU3MDKZMywwTYQpZ6IQWRViNFAWnsuRUJYKHaiRPlBa75Mc6t3Pt_YC-z5fWl1jXusF28DlLszRmcUJ5oIdrWrrWe4dV3jm71O4xZzR_bz3fth7st03sUCzRbOW_mgP4vgZ_tbtDtwW3F5friLwzVVAH_1WbL28npo_x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1686414502</pqid></control><display><type>article</type><title>Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients</title><source>MEDLINE</source><source>Karger Journals</source><creator>Waldhoer, Thomas ; Berger, Ingrid ; Haidinger, Gerald ; Zielonke, Nadine ; Madersbacher, Stephan</creator><creatorcontrib>Waldhoer, Thomas ; Berger, Ingrid ; Haidinger, Gerald ; Zielonke, Nadine ; Madersbacher, Stephan</creatorcontrib><description>Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (<70 years and ≥70 years) with higher tumour stages. Conclusions: This population-based study demonstrates that (1) a rise of advanced bladder cancer stages in women and (2) that women with tumour stages >pT1 have a shorter cancer-specific and overall survival.</description><identifier>ISSN: 0042-1138</identifier><identifier>EISSN: 1423-0399</identifier><identifier>DOI: 10.1159/000368418</identifier><identifier>PMID: 25833466</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Aged ; Aged, 80 and over ; Austria - epidemiology ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Original Paper ; Registries ; Risk Factors ; Sex Factors ; Time Factors ; Treatment Outcome ; Urinary Bladder Neoplasms - mortality ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - therapy</subject><ispartof>Urologia internationalis, 2015-01, Vol.94 (4), p.383-389</ispartof><rights>2015 S. Karger AG, Basel</rights><rights>2015 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-14f752ba39799bc30d41de61a78e53db7ba50bba78d73b207c2095328417259a3</citedby><cites>FETCH-LOGICAL-c369t-14f752ba39799bc30d41de61a78e53db7ba50bba78d73b207c2095328417259a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25833466$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waldhoer, Thomas</creatorcontrib><creatorcontrib>Berger, Ingrid</creatorcontrib><creatorcontrib>Haidinger, Gerald</creatorcontrib><creatorcontrib>Zielonke, Nadine</creatorcontrib><creatorcontrib>Madersbacher, Stephan</creatorcontrib><title>Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients</title><title>Urologia internationalis</title><addtitle>Urol Int</addtitle><description>Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (<70 years and ≥70 years) with higher tumour stages. Conclusions: This population-based study demonstrates that (1) a rise of advanced bladder cancer stages in women and (2) that women with tumour stages >pT1 have a shorter cancer-specific and overall survival.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Austria - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Original Paper</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Urinary Bladder Neoplasms - mortality</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urinary Bladder Neoplasms - therapy</subject><issn>0042-1138</issn><issn>1423-0399</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0M9O20AQBvBV1aqk0AN3VI3US5Fi2D-219tbEiggRYBEUI_W2jtG2zq22bUjeAAOPAgvxpOwKGlOPY1G89M30kfIPqNHjCXqmFIq0ixm2QcyYjEXERVKfSQjSmMeMSayHfLF-z-UBqzkZ7LDk0yIOE1H5OkGH-DEVhU6bEr00Fbw-vzSLRhMa20MOpjpcHBwM7iVXekabAOTwffO6p8wgRP0pbNdb1c4hnnb3EULdMsxXOretk302xqESaPrR289TLVHA20DXI6lFHAdEDa93yOfKl17_LqZu-T21-lidh7Nr84uZpN5VIpU9RGLK5nwQgsllSpKQU3MDKZMywwTYQpZ6IQWRViNFAWnsuRUJYKHaiRPlBa75Mc6t3Pt_YC-z5fWl1jXusF28DlLszRmcUJ5oIdrWrrWe4dV3jm71O4xZzR_bz3fth7st03sUCzRbOW_mgP4vgZ_tbtDtwW3F5friLwzVVAH_1WbL28npo_x</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Waldhoer, Thomas</creator><creator>Berger, Ingrid</creator><creator>Haidinger, Gerald</creator><creator>Zielonke, Nadine</creator><creator>Madersbacher, Stephan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients</title><author>Waldhoer, Thomas ; Berger, Ingrid ; Haidinger, Gerald ; Zielonke, Nadine ; Madersbacher, Stephan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-14f752ba39799bc30d41de61a78e53db7ba50bba78d73b207c2095328417259a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Austria - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Original Paper</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Urinary Bladder Neoplasms - mortality</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urinary Bladder Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waldhoer, Thomas</creatorcontrib><creatorcontrib>Berger, Ingrid</creatorcontrib><creatorcontrib>Haidinger, Gerald</creatorcontrib><creatorcontrib>Zielonke, Nadine</creatorcontrib><creatorcontrib>Madersbacher, Stephan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urologia internationalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waldhoer, Thomas</au><au>Berger, Ingrid</au><au>Haidinger, Gerald</au><au>Zielonke, Nadine</au><au>Madersbacher, Stephan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients</atitle><jtitle>Urologia internationalis</jtitle><addtitle>Urol Int</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>94</volume><issue>4</issue><spage>383</spage><epage>389</epage><pages>383-389</pages><issn>0042-1138</issn><eissn>1423-0399</eissn><abstract>Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (<70 years and ≥70 years) with higher tumour stages. Conclusions: This population-based study demonstrates that (1) a rise of advanced bladder cancer stages in women and (2) that women with tumour stages >pT1 have a shorter cancer-specific and overall survival.</abstract><cop>Basel, Switzerland</cop><pmid>25833466</pmid><doi>10.1159/000368418</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0042-1138 |
| ispartof | Urologia internationalis, 2015-01, Vol.94 (4), p.383-389 |
| issn | 0042-1138 1423-0399 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1686414502 |
| source | MEDLINE; Karger Journals |
| subjects | Aged Aged, 80 and over Austria - epidemiology Female Humans Incidence Kaplan-Meier Estimate Male Middle Aged Neoplasm Staging Original Paper Registries Risk Factors Sex Factors Time Factors Treatment Outcome Urinary Bladder Neoplasms - mortality Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - therapy |
| title | Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A25%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sex%20Differences%20of%20%E2%89%A5pT1%20Bladder%20Cancer%20Survival%20in%20Austria:%20A%20Descriptive,%20Long-Term,%20Nation-Wide%20Analysis%20Based%20on%2027,773%20Patients&rft.jtitle=Urologia%20internationalis&rft.au=Waldhoer,%20Thomas&rft.date=2015-01-01&rft.volume=94&rft.issue=4&rft.spage=383&rft.epage=389&rft.pages=383-389&rft.issn=0042-1138&rft.eissn=1423-0399&rft_id=info:doi/10.1159/000368418&rft_dat=%3Cproquest_karge%3E1686414502%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1686414502&rft_id=info:pmid/25833466&rfr_iscdi=true |